On September 5, 2019 Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium"), reported that it will present at the Rodman & Renshaw 21st Annual Global Investment Conference (Press release, Actinium Pharmaceuticals, SEP 5, 2019, View Source;renshaw-21st-annual-global-investment-conference-300912476.html [SID1234539324]). The conference is being held at the Lotte New York Palace Hotel in New York City on September 8-10, 2019. Details of Actinium’s presentation are as follows:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Date: Tuesday, September 10, 2019
Time: 4:40 PM ET
Room: Holmes I (4th Floor)
Venue: Lotte New York Palace Hotel

Members of Actinium’s Executive team will be available for 1-on-1 meetings with conference attendees. Those interested in scheduling a meeting with Actinium may do so by contacting Steve O’Loughlin, Actinium’s Principal Financial Officer via email at [email protected].